Skip to Content
Merck
  • The effect of alendronate-loaded polycarprolactone nanofibrous scaffolds on osteogenic differentiation of adipose-derived stem cells in bone tissue regeneration.

The effect of alendronate-loaded polycarprolactone nanofibrous scaffolds on osteogenic differentiation of adipose-derived stem cells in bone tissue regeneration.

Journal of biomedical nanotechnology (2014-04-23)
Young-Pil Yun, Seung-Ju Kim, Youn-Mook Lim, Kyeongsoon Park, Hak-Jun Kim, Sung-In Jeong, Sung Eun Kim, Hae-Ryong Song
ABSTRACT

The osteogenic effect of culturing adipose-derived stem cells (ADSCs) on alendronate (Aln)-loaded polycarprolactone (PCL) nanofibrous scaffolds was evaluated by examining alkaline phosphatase (ALP) activity, calcium content, and expression of osteogenic differentiation genes in vitro. The 10% Aln/PCL nanofibrous scaffolds showed more ALP activity, mineralization, and osteocalcin and osteopontin mRNA than the 1% or 5% Aln/PCL nanofibrous scaffolds. The capacity of Aln/PCL nanofibrous scaffolds to regenerate new bone was studied in a rat calvarial defect model. New bone formation in vivo was evaluated by radiography, micro-computed tomography, and histological analysis. At 8 weeks after implantation, Aln/PCL scaffolds had a positive effect on bone regeneration and matrix formation. These results suggested that Aln/PCL nanofibrous scaffolds enhanced the osteogenic differentiation of ADSCs in vitro and bone formation in vivo.

MATERIALS
Product Number
Brand
Product Description

USP
Alendronate sodium, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Alendronate sodium trihydrate, ≥97% (NMR), powder